Comparison Three vs Twelve Months of Dual Anti-Platelet Therapy After Stent Implantation
Status:
Recruiting
Trial end date:
2022-10-01
Target enrollment:
Participant gender:
Summary
This study is a prospective,multi-center, open-label, randomized controlled clinical
trial,aims to assess the clinical noninferiority of 3 months (short-term) vs 12 months
(long-term) of Dual Anti-Platelet Therapy (DAPT) in patients undergoing percutaneous coronary
intervention implanted sirolimus target- eluting stent with abluminal grooves containing a
biodegradable polymer (Firehawk⢠stent). All participants met the inclusion criteria begin
taking aspirin and open-label thienopyridine therapy before index procedure, and will be 1:1
randomized to 3 months or 12 month of DAPT at index procedure.